Intrinsiqq
Acacia Research Corporation logo

Acacia Research Corporation (ACTG) Insider Trading

Last 12 months

Insiders sold $458k and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. Director Maureen Oconnell sold $152k on Sep 3, 11% of their stake, outside a plan. The last open-market buy by an executive or director was in Aug 2025.

Net open-market
−$458k
0 buys · 4 sales
Under a 10b5-1 plan
0%
of the value sold
Insiders who bought / sold
0 / 2
executives and directors
Last open-market buy
Aug 2025
Aug 11, 2025

Get an email when ACTG's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Sep 15No plan
    Isaac T. Kohlberg
    Director · sold 24,000 at $4.55
    $109k
    31% of stake
  • Sep 2 – 3No plan
    Maureen Oconnell
    Director · sold 33,000 at avg $4.61
    $152k
    11% of stake
  • Aug 19No plan
    Maureen Oconnell
    Director · sold 10,000 at $4.60
    $46k
    3.4% of stake
  • Aug 12No plan
    Isaac T. Kohlberg
    Director · sold 32,188 at $4.67
    $150k
    29% of stake
  • Aug 11, 2025
    Michael Sikoryak Zambito
    Chief Financial Officer · bought 7,700 at $3.27
    $25k
    New position
  • Jun 11, 2025No plan
    Isaac T. Kohlberg
    Director · sold 16,000 at $3.84
    $61k
    16% of stake
  • May 21, 2025
    Jason W. Soncini
    General Counsel · bought 7,000 at $3.79
    $27k
    3.5% of stake
  • May 19, 2025
    Martin D. McNulty Jr.
    Chief Executive Officer · bought 5,300 at $3.77
    $20k
    2.9% of stake
  • Nov 25, 2024No plan
    Isaac T. Kohlberg
    Director · sold 15,000 at $4.57
    $69k
    18% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch ACTG, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Patent Owners & Lessors

Spot a number that looks wrong? Check it in ACTG's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing ACTG

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.